--- title: "Genenta Science surges 20% during regular trading" type: "News" locale: "en" url: "https://longbridge.com/en/news/303971732.md" description: "Genenta Science rose 19.68% to US$0.7400. Down 51.01% YTD." datetime: "2026-11-02T15:14:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/303971732.md) - [en](https://longbridge.com/en/news/303971732.md) - [zh-HK](https://longbridge.com/zh-HK/news/303971732.md) generator: "portal-rs" --- # Genenta Science surges 20% during regular trading Genenta Science (GNTA.US) surged nearly **20%** during regular trading to **$0.74**. The stock is down 51.01% year to date and sits 34.55% above its 52-week low of US$0.5500. Volume was 68.60 times its average and the intraday swing reached 11.14%. The Nasdaq Composite is down 1.81% over the past five sessions and up 10.56% year to date. Based on public media reports. AI-generated; not investment advice. ### Related Stocks - [GNTA.US](https://longbridge.com/en/quote/GNTA.US.md) - [SAEN.US](https://longbridge.com/en/quote/SAEN.US.md) ## Related News & Research - [Space Exploration Technologies (SPCX) Gets A New Hiring Twist As Musk Eyes Top AI Talent](https://longbridge.com/en/news/306383945.md) - [Why Is SoundHound AI (SOUN) Serving Nearly 8 Million Residents In Bogotá?](https://longbridge.com/en/news/306367933.md) - [Salesforce (CRM) Chosen To Lead U.S. Backed Super Intelligence Export Group](https://longbridge.com/en/news/306383121.md) - [CAPR: FDA issued a CRL for Deramiocel, citing insufficient evidence of effectiveness](https://longbridge.com/en/news/306366333.md) - [MOG.A: FY27 guidance targets 9% sales growth and a 14.2% adjusted segment margin](https://longbridge.com/en/news/306365896.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**